SABSW
Financials
- Market Capitalization 344.8383 M
- Employee 86
- Founded 2014
- CEO N/A
- Website www.sab.bio
- Headquarter Delaware, United States
- FIGI BBG00YHY0G24
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 6797 |  DRTSW Alpha Tau Medical Ltd. - Warrant | 3.7900 USD | -5.25% | -10.10% | +53.75% | +1387.44% | 1.29 B USD | ||
| 6911 |  RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0007 USD | -30.00% | -81.58% | -50.00% | -98.24% | 423.73 M USD | ||
| 6971 |  YDESW YD Bio Limited - Warrants | 0.4174 USD | +19.26% | +61.53% | +66.96% | -13.04% | 339.79 M USD | ||
| 7160 |  HUMAW Humacyte, Inc. - Warrant | 0.0009 USD | 0.00% | -82.00% | -90.00% | -99.55% | 180.57 M USD |
Frequently asked questions about SAB Biotherapeutics, Inc. Common Stock
What is the SAB Biotherapeutics, Inc. Common Stock stock price today?
The current price of SAB Biotherapeutics, Inc. Common Stock (SABSW) is 0.0258. Over the past 24 hours, the stock has changed by +1.57%. Follow the SABSW chart for real-time price dynamics.
What is the stock ticker of SAB Biotherapeutics, Inc. Common Stock?
SAB Biotherapeutics, Inc. Common Stock trades under the ticker SABSW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is SAB Biotherapeutics, Inc. Common Stock stock going up?
SABSW has changed by -0.77% over the last week, +158.00% over the last month, and +1.18% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of SAB Biotherapeutics, Inc. Common Stock?
SAB Biotherapeutics, Inc. Common Stock currently has a market capitalization of 344.84 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were SAB Biotherapeutics, Inc. Common Stock earnings last quarter?
Last quarter, SAB Biotherapeutics, Inc. Common Stock reported earnings of -0.28 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was SAB Biotherapeutics, Inc. Common Stock revenue for the last quarter?
SAB Biotherapeutics, Inc. Common Stock reported quarterly revenue of 13.82 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was SAB Biotherapeutics, Inc. Common Stock net income for the last quarter?
SAB Biotherapeutics, Inc. Common Stock reported net income of -22.49 M for the last quarter. The previous quarter showed -18.87 M, which means net income changed by -19.20%.
How many employees does SAB Biotherapeutics, Inc. Common Stock have?
As of the latest available data, SAB Biotherapeutics, Inc. Common Stock has 86 employees. Workforce size can provide additional context about the company's scale and operations.
What is SAB Biotherapeutics, Inc. Common Stock EBITDA?
SAB Biotherapeutics, Inc. Common Stock EBITDA is -22.56 M, and its EBITDA margin is -163.24 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy SAB Biotherapeutics, Inc. Common Stock stock?
You can buy SAB Biotherapeutics, Inc. Common Stock (SABSW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in SAB Biotherapeutics, Inc. Common Stock stock?
Investing in SAB Biotherapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SABSW chart and related analysis on metatrader.com as part of your research.